New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate
Authors:
Open Access
- 1 March 2021
- journal article
- editorial
- Published by Wiley in Clinical Case Reports
- Vol. 9 (3) , 1797-1798
Abstract
The sinoatrial block is a new side effect of meglumine antimoniate. Prompt interruption of the drug results in the normalization of electrographic changes and prevents sudden cardiac arrest.Keywords
This publication has 3 references indexed in Scilit:
- Toxicité cardiaque de l'antimoniate de méglumine (Glucantime®). À propos d'une observationMedecine Et Maladies Infectieuses, 2007
- Antimony-Based Antileishmanial Compounds Prolong the Cardiac Action Potential by an Increase in Cardiac Calcium CurrentsMolecular Pharmacology, 2006
- A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate.The American Journal of Tropical Medicine and Hygiene, 1998